Can antiviral therapy prevent cirrhosis?

Whether antiviral therapy can prevent cirrhosis needs to be analyzed according to specific circumstances: 1. **Targeting the cause**: If cirrhosis is caused by viral hepatitis (e.g., hepatitis B or C), antiviral treatment can, to some extent, halt disease progression and reduce the risk of developing cirrhosis. This is because antiviral medications effectively suppress viral replication, thereby reducing liver inflammation and the degree of fibrosis. 2. **Variable treatment outcomes**: The effectiveness of antiviral therapy is not absolute and is influenced by multiple factors, including the patient's age, severity of liver disease, viral genotype, and adherence to treatment. Therefore, not all patients with viral hepatitis receiving antiviral therapy will completely avoid developing cirrhosis. 3. **Comprehensive management**: For patients who have already developed cirrhosis, antiviral therapy should be combined with other treatment strategies, such as hepatoprotective measures, enzyme-lowering therapies, and anti-fibrotic treatments, to comprehensively control the disease and slow its progression.